Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: implications for the dopaminergic neurotoxicity of HPP+.

Source:http://linkedlifedata.com/resource/pubmed/id/15639785

Download in:

View as

General Info

PMID
15639785